BridgeBio Pharma, Inc.
BBIO
24 insider filings · Latest: Jun 15, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| Mar 10, 2026 | Mar 10 8:02 PM | HANNAH A VALANTINE | Proposed Sale | 8,671 | $72.00 | $624.3K | — | View → |
| Mar 4, 2026 | Mar 6 9:57 PM | Andrea EllisDirector | Sale | 64,921 | $64.87 | $4.2M | 18,589(D) | View → |
| Mar 4, 2026 | Mar 4 9:17 PM | ANDREA ELLIS | Proposed Sale | 64,921 | $64.87 | $4.2M | — | View → |
| Feb 27, 2026 | Mar 3 9:17 PM | Hannah ValantineDirector | Sale | 25,484 | $67.41 | $1.7M | 7,465(D) | View → |
| Feb 27, 2026 | Feb 27 9:20 PM | HANNAH A VALANTINE | Proposed Sale | 25,484 | $67.41 | $1.7M | — | View → |
| Feb 26, 2026 | Feb 27 9:11 PM | Maricel ApuliChief Accounting Officer | Sale | 2,000 | $66.00 | $132.0K | 121,945(D) | View → |
| Feb 19, 2026 | Feb 23 9:32 PM | Neil KumarDirector, Chief Executive Officer | Sale | 28,053 | $71.39 | $2.0M | 234,451(D) | View → |
| Feb 19, 2026 | Feb 19 9:22 PM | NEIL KUMAR | Proposed Sale | 28,053 | $73.93 | $2.1M | — | View → |
| Feb 17, 2026 | Feb 18 11:39 PM | Maricel ApuliChief Accounting Officer | Sale | 510 | $74.31 | $37.9K | 123,945(D) | View → |
| Feb 17, 2026 | Feb 18 11:36 PM | Thomas TrimarchiPresident and CFO | Sale | 13,600 | $74.72 | $1.0M | 336,585(D) | View → |
| Feb 17, 2026 | Feb 18 11:34 PM | Randal W. ScottDirector | Sale | 10,000 | $75.46 | $754.6K | 11,589(D) | View → |
| Feb 17, 2026 | Feb 17 9:40 PM | RANDAL SCOTT | Proposed Sale | 20,000 | $75.25 | $1.5M | — | View → |
| Feb 17, 2026 | Feb 17 9:06 PM | THOMAS TRIMARCHI | Proposed Sale | 13,600 | $74.72 | $1.0M | — | View → |
| Feb 11, 2026 | Feb 12 9:39 PM | Neil KumarDirector, Chief Executive Officer | Sale | 40,000 | $71.78 | $2.9M | 4,478,447(I) | View → |
| Feb 10, 2026 | Feb 12 9:39 PM | Neil KumarDirector, Chief Executive Officer | Sale | 40,000 | $71.94 | $2.9M | 4,498,447(I) | View → |
| Jan 8, 2026 | Jan 8 9:23 PM | KUMAR HALDEA REVOCABLE TRUST U/A DTD 12/19/2018 | Proposed Sale | 120,000 | $74.27 | $8.9M | — | View → |
| Jan 8, 2026 | Jan 8 9:23 PM | KUMAR HALDEA FAMILY IRREVOCABLE TRUST | Proposed Sale | 100,000 | $74.27 | $7.4M | — | View → |
| Dec 15, 2025 | Dec 15 9:23 PM | NEIL KUMAR | Proposed Sale | 30,011 | $75.15 | $2.3M | — | View → |
| Nov 20, 2025 | Nov 20 9:20 PM | NEIL KUMAR | Proposed Sale | 26,156 | $65.54 | $1.7M | — | View → |
| Nov 18, 2025 | Nov 18 9:06 PM | ANDREW W LO | Proposed Sale | 55,000 | $65.69 | $3.6M | — | View → |
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| Jun 15, 2026 | Jun 17 8:45 PM | Jennifer E. CookDirector | Option Exercise | 83,088 | $16.75 | 34,334(D) | View → |
| May 16, 2026 | May 19 8:27 PM | Neil KumarDirector, Chief Executive Officer | Option Exercise | 71,215 | — | 97,794(D) | View → |
| May 15, 2026 | May 19 8:25 PM | Randal W. ScottDirector | Option Exercise | 10,000 | $16.75 | 21,501(D) | View → |
| Mar 17, 2026 | Mar 19 8:28 PM | Neil KumarDirector, Chief Executive Officer | Grant/Award | 144,883 | $70.94 | 104,313(D) | View → |
| Mar 10, 2026 | Mar 12 8:15 PM | Hannah ValantineDirector | Option Exercise | 8,671 | $27.36 | 17,343(D) | View → |
| Mar 4, 2026 | Mar 6 9:57 PM | Andrea EllisDirector | Option Exercise | 64,921 | $8.45 | 0(D) | View → |
| Feb 27, 2026 | Mar 3 9:17 PM | Hannah ValantineDirector | Option Exercise | 25,484 | $48.45 | 0(D) | View → |
| Feb 16, 2026 | Feb 18 11:41 PM | Neil KumarDirector, Chief Executive Officer | Option Exercise | 64,698 | — | 138,645(D) | View → |
| Feb 17, 2026 | Feb 18 11:34 PM | Randal W. ScottDirector | Option Exercise | 10,000 | $16.75 | 31,501(D) | View → |